These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. [Therapy and follow-up of bladder cancer]. Meyer D; Schmid HP; Engeler DS Wien Med Wochenschr; 2007; 157(7-8):162-9. PubMed ID: 17492413 [TBL] [Abstract][Full Text] [Related]
12. Neoadjuvant combined modality program with selective organ preservation for invasive bladder cancer: results of Radiation Therapy Oncology Group phase II trial 8802. Tester W; Caplan R; Heaney J; Venner P; Whittington R; Byhardt R; True L; Shipley W J Clin Oncol; 1996 Jan; 14(1):119-26. PubMed ID: 8558186 [TBL] [Abstract][Full Text] [Related]
13. Assessment and management of deeply invasive and metastatic lesions. Whitmore WF Cancer Res; 1977 Aug; 37(8 Pt 2):2756-8. PubMed ID: 872102 [No Abstract] [Full Text] [Related]
14. Organ conservation and reconstruction in advanced bladder cancer. Sternberg CN Prog Clin Biol Res; 1991; 370():131-42. PubMed ID: 1924442 [No Abstract] [Full Text] [Related]
15. [Conservative treatment with chemotherapy and radiotherapy in bladder cancer invading the muscle: preliminary results of a prospective study]. Zapatero A; Pinar B; Arellano R; López M; Marín A; Jiménez U; Pérez Torrubia A Arch Esp Urol; 1997 Jun; 50(5):448-54; discussion 454-6. PubMed ID: 9382586 [TBL] [Abstract][Full Text] [Related]
16. Endpoints of clinical trials for muscle-invasive bladder cancer. Tannock IF Prog Clin Biol Res; 1990; 353():65-74. PubMed ID: 2217428 [No Abstract] [Full Text] [Related]
17. Evaluation criteria: a protocol to study patterns of care and their effects in patients with transitional cell carcinoma of the bladder (protocol 1). Prout GR; Kopp J Prog Clin Biol Res; 1984; 162A():285-99. PubMed ID: 6483913 [No Abstract] [Full Text] [Related]
18. The role of combined method in organ-sparing treatment of muscle-invasive bladder cancer recurrences. Startsev VY Arch Ital Urol Androl; 2002 Jun; 74(2):54-6. PubMed ID: 12161935 [TBL] [Abstract][Full Text] [Related]
19. Treatment of muscle-invasive and metastatic bladder cancer: update of the EAU guidelines. Stenzl A; Cowan NC; De Santis M; Kuczyk MA; Merseburger AS; Ribal MJ; Sherif A; Witjes JA; Eur Urol; 2011 Jun; 59(6):1009-18. PubMed ID: 21454009 [TBL] [Abstract][Full Text] [Related]